Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) FCF Margin (2020 - 2026)

RxSight filings provide 6 years of FCF Margin readings, the most recent being 6.91% for Q4 2025.

  • On a quarterly basis, FCF Margin rose 1623.0% to 6.91% in Q4 2025 year-over-year; TTM through Dec 2025 was 14.38%, a 162.0% increase, with the full-year FY2025 number at 14.38%, up 162.0% from a year prior.
  • FCF Margin hit 6.91% in Q4 2025 for RxSight, down from 5.83% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 1.38% in Q3 2024 to a low of 308.55% in Q1 2021.
  • Median FCF Margin over the past 5 years was 42.79% (2023), compared with a mean of 87.85%.
  • Biggest five-year swings in FCF Margin: crashed -21042bps in 2021 and later soared 13684bps in 2022.
  • RxSight's FCF Margin stood at 124.9% in 2021, then rose by 20bps to 100.05% in 2022, then soared by 71bps to 29.29% in 2023, then increased by 21bps to 23.14% in 2024, then skyrocketed by 70bps to 6.91% in 2025.
  • The last three reported values for FCF Margin were 6.91% (Q4 2025), 5.83% (Q3 2025), and 18.68% (Q2 2025) per Business Quant data.